Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.

Nita G. Forouhi,Rk Menon,Stephen J. Sharp,N. Mannan,P. M. Timms,Adrian R. Martineau,Rickard Ap,Barbara J. Boucher,Tahseen A Chowdhury,Chris Griffiths,Stephen E. Greenwald,Simon J. Griffin,Graham A. Hitman

Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.

2016

Nita G. Forouhi
Rk Menon
Stephen J. Sharp
N. Mannan
P. M. Timms
Adrian R. Martineau
Rickard Ap
Barbara J. Boucher
Tahseen A Chowdhury
Chris Griffiths
Stephen E. Greenwald
Simon J. Griffin
Graham A. Hitman

Aims To investigate the effect of short‐term vitamin D supplementation on cardiometabolic outcomes among individuals with an elevated risk of diabetes.

Keywords:

Type 2 diabetes
Cohort study
Placebo
Vitamin
Vitamin D and neurology
Calcifediol
Placebo-controlled study
Pediatrics
Diabetes mellitus
Medicine
Cholecalciferol

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations